Singapore markets closed

LLY Jan 2026 570.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
263.640.00 (0.00%)
As of 02:32PM EDT. Market open.
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    Stocks open in the green, Dow hopeful to claw back losses

    Stocks (^DJI, ^IXIC, ^GSPC) edge higher at Friday's open, hoping to reclaim slight losses ahead of the long Memorial Day Weekend. Yahoo Finance Senior Markets Reporter Jared Blikre joins the Morning Brief to examine the market direction and this morning's across-the-board sector gains. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Associated Press Finance

    Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro

    Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its popular weight-loss and diabetes treatments, Zepbound and Mounjaro. The company broke ground for its Lebanon, Indiana, manufacturing plant last year and expects to start making products there near the end of 2026. Lilly said it would add $5.3 billion to the $3.7 billion it had already slated for the site.

  • Reuters

    Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars

    (Reuters) -Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs. The new investment, which brings the total to $9 billion, will help boost production of the active pharmaceutical ingredients (API) for Lilly's powerful weight-loss drug Zepbound and diabetes treatment Mounjaro, the company said. “Today’s announcement tops the largest manufacturing investment in our company’s history and, we believe, represents the single largest investment in synthetic medicine API manufacturing in U.S. history,” said Lilly CEO David Ricks.